Bio-Rad Reports Fourth-Quarter and Full-Year 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Bio-Rad Labs (BIO) Misses Q4 EPS by 12c
February 13, 2020 4:28 PM ESTBio-Rad Labs (NYSE: BIO) reported Q4 EPS of $2.32, $0.12 worse than the analyst estimate of $2.44. Revenue for the quarter came in at $624.4 million versus the consensus estimate of $641.95 million.
Aside from the impact of the cyberattack on our network in December, sales performance for the... More
